Brokerages Set GSK plc (LON:GSK) Price Target at GBX 1,862.50

Shares of GSK plc (LON:GSK - Get Free Report) have been given a consensus rating of "Moderate Buy" by the six research firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation and five have given a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is GBX 1,862.50 ($25.27).

Several analysts recently weighed in on the stock. Shore Capital reiterated a "buy" rating on shares of GSK in a research report on Wednesday, April 30th. JPMorgan Chase & Co. restated an "underweight" rating on shares of GSK in a research note on Friday, March 28th.

GSK Stock Performance

Shares of LON:GSK traded down GBX 38 ($0.52) during trading on Friday, hitting GBX 1,511.50 ($20.51). 9,561,022 shares of the company traded hands, compared to its average volume of 14,658,150. The stock has a market capitalization of £61.33 billion, a price-to-earnings ratio of 24.42, a PEG ratio of 1.24 and a beta of 0.31. GSK has a one year low of GBX 1,242.50 ($16.86) and a one year high of GBX 1,678.68 ($22.78). The company has a quick ratio of 0.73, a current ratio of 0.81 and a debt-to-equity ratio of 114.64. The business's fifty day moving average is GBX 1,408.26 and its 200-day moving average is GBX 1,408.36.

GSK (LON:GSK - Get Free Report) last issued its earnings results on Wednesday, April 30th. The company reported GBX 44.90 ($0.61) earnings per share for the quarter. GSK had a return on equity of 18.08% and a net margin of 8.02%. As a group, equities analysts predict that GSK will post 175.980975 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, insider Wendy Becker acquired 536 shares of the business's stock in a transaction dated Thursday, March 20th. The stock was acquired at an average price of GBX 1,515 ($20.56) per share, for a total transaction of £8,120.40 ($11,018.18). Also, insider Emma Walmsley sold 5,473 shares of GSK stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of GBX 1,449 ($19.66), for a total value of £79,303.77 ($107,603.49). Corporate insiders own 1.61% of the company's stock.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.